tenk.fyi

Metagenomi Therapeutics, Inc.

MGXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$25.2M

51.8% YoY

Net Income

-$87.9M

12.6% YoY

EPS

$-2.36

0.0% YoY

Cash

$41.7M

52.3% YoY

FY 2025 · As of 2025-12-31